Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9788
Title: Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.
Austin Authors: Krauer, K G;McKenzie, Ian F C;Pietersz, Geoffrey A
Affiliation: Austin Research Institute, Austin Hospital, Heidelberg, Victoria, Australia
Issue Date: 1-Jan-1992
Publication information: Cancer Research; 52(1): 132-7
Abstract: The conjugation of antineoplastic drugs to monoclonal antibodies reactive with tumor associated antigens conveys selective cytotoxicity, overcoming the systemic toxicities caused by drugs during standard chemotherapy. 2'-Deoxy-5-fluorouridine, a more potent derivative of 5-fluorouracil, is an antimetabolite which exerts its cytotoxic action by inhibiting the enzyme thymidylate synthetase and as a result inhibits DNA synthesis. 2'-Deoxy-5-fluorouridine was successfully conjugated to anti-Ly-2.1 reactive with the murine thymoma ITT(1)75NS E3, I-1, and 250-30.6 reactive with human colon cancer cells using the active ester of 2'-deoxy-5-fluoro-3'-O-succinoyluridine (5FdUrdsucc). In vitro, 5Fd-Urdsucc-anti-Ly-2.1 was selectively cytotoxic against ITT(1)75NS E3 murine thymoma cells at nanomolar concentrations. The human colon carcinoma cell LIM1899 was inhibited by 5FdUrdsucc-I-1 conjugates in the range of 10(-7)-10(-8) M, as were Colo 205 cells by 5FdUrdsucc-250-30.6 conjugates. In vivo, 5FdUrdsucc conjugates were more effective than equivalent amounts of free 5FdUrdsucc. Against the ITT(1)75NS E3 murine thymoma, a single dose of 100 micrograms (5FdUrdsucc equivalents) 5FdUrdsucc-anti-Ly-2.1 resulted in 85% tumor inhibition compared to mean tumor size of control mice. Irrelevant 5FdUrdsucc conjugates failed to inhibit tumor growth. Multiple doses of 5FdUrdsucc-I-1 conjugate produced 50% growth inhibition of the moderately differentiated tumor LIM1899. In contrast, the human colon carcinoma Colo 205 was relatively resistant to free 5FdUrdsucc and 5FdUrdsucc-250-30.6 conjugates.
Gov't Doc #: 1530766
URI: https://ahro.austin.org.au/austinjspui/handle/1/9788
Journal: Cancer research
URL: https://pubmed.ncbi.nlm.nih.gov/1530766
Type: Journal Article
Subjects: Animals
Antibodies, Monoclonal.metabolism.therapeutic use
Colonic Neoplasms.metabolism.therapy
Drug Screening Assays, Antitumor
Floxuridine.metabolism.therapeutic use
Humans
Immunotoxins.metabolism.therapeutic use
Mice
Neoplasm Transplantation
Thymoma.metabolism.therapy
Thymus Neoplasms.metabolism.therapy
Tumor Cells, Cultured
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on May 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.